Toagosei (4045) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
10 Mar, 2026Executive summary
FY2025 net sales declined 3.2% to ¥162.3 billion, operating income was nearly flat at ¥14.18 billion, and net income attributable to owners of parent rose 7.5% to ¥12.77 billion, driven by cross-shareholding sales.
The business environment featured global growth, Japanese inflation outpacing wage growth, and continued stagnation in China, impacting chemical product flows and costs.
Shareholder returns were robust, with a 65 yen annual dividend (up 5 yen year-over-year), total returns at 110.1%, and share buybacks and cancellations executed.
The group focused on sales expansion, cost reductions, capital investment, R&D, and overseas expansion, including a new subsidiary in India.
Financial highlights
Net sales for FY2025 were ¥162.3 billion (down 3.2% year-over-year); operating income was ¥14.18 billion (down 0.4%).
Net income attributable to owners of parent increased 7.5% to ¥12.77 billion; EPS rose 11.9% to ¥117.02.
Annual dividend increased to ¥65 per share, payout ratio 55.5%.
Cash and equivalents at year-end fell by ¥11.67 billion to ¥28.76 billion, mainly due to capital investment and share buybacks.
Comprehensive income was ¥16.14 billion, up 5.2% year-over-year.
Outlook and guidance
FY2026 net sales forecast at ¥167 billion (+2.9%), operating income at ¥14.5 billion (+2.3%), and net income attributable to owners of parent at ¥11.5 billion (−9.9%).
Dividend forecast for FY2026 is ¥70 per share (payout ratio 64.5%), with a targeted payout ratio of ~70% and total shareholder returns of ~90%.
Share buyback of up to ¥3.0 billion authorized for FY2026.
Focus areas include absorbing higher fixed costs, expanding profitability of prior investments, and accelerating new business development.
Latest events from Toagosei
- Strong 1H FY2024 growth drives higher full-year forecasts and increased shareholder returns.4045
Q2 202410 Mar 2026 - FY2024 saw higher sales, profits, and dividends, with FY2025 targeting further profit growth.4045
Q4 202410 Mar 2026 - Strong sales, profit, and EPS growth with robust 2024 guidance and stable dividend.4045
Q3 202410 Mar 2026 - Net sales rose 2.1% year-over-year, but profits fell and dividend forecast increased amid uncertainty.4045
Q1 202510 Mar 2026 - Sales and profits fell, outlook was lowered, and U.S. adhesives business was restructured.4045
Q2 202510 Mar 2026 - Net sales and profits fell year-over-year, but the dividend payout is set to rise.4045
Q3 202510 Mar 2026